Registration is closed

AAADV not only impacts the rate at which oncology drugs are brought to market, but patients afflicted with cancer have been able to appreciate significant advances in their care and survival rates.

Richard Pazdur

Director, Oncology Center of Excellence

U.S. Food and Drug Administration Center for Drug Evaluation and Research


15th Annual AAADV Workshop

Leaders in clinical and translational cancer research from academic, industry, government and the nonprofit advocacy sector focus on understanding and efficiently negotiating the drug development process.

May 2-4, 2018

Enroll Now


Download AAADV Mobile app for Android and iOS

google -play-image apple-store-image

Message from the Program Chair